Helpdesk

Sales contact

Home > Ophthalmology

Ophthalmology

Case study

Ophthalmology Clinical Trials

Ophthalmic conditions and vision impairment currently affect 2.2 billion people globally: Data collection can be very challenging for patients with visual impairment, but the patient- and site-centric research approach that...

eCOA in ophthalmology

Ophthalmology

There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of...

Key #5 for successful ePRO selection in your ophthalmology clinical trial: Anticipate cultural differences in multi country clinical trials

Ophthalmology

https://youtu.be/-dWvQaRUwYs Before selecting a PRO for use in a large global trial, it is important to anticipate that responses to...

Key #4 for successful ePRO selection in your ophthalmology clinical trial: Consider the method of ePRO administration

Ophthalmology

https://youtu.be/cY5lYM_wBDQ PROs in ophthalmology trials can either be self-administered by the patient or the responses can be collected through an...

Key #3 for successful ePRO selection in your ophthalmology clinical trial: Get your patients involved

Ophthalmology

https://youtu.be/Cp7vd1fBKbc Although clinical research stakeholders strive to be patient-centered in their approach, dependence on clinical parameters alone is not enough....

Key #2 for successful ePRO selection in your ophthalmology clinical trial: Use your PROs to power economic evaluations

Ophthalmology

https://youtu.be/rH4yG-sxE9w Incorporating an economic evaluation within a trial provides valuable information for clinical decision making and coverage determinations, particularly when...

Infographic

Key #1 for successful ePRO selection in your ophthalmology clinical trial: Ensure the ePRO answers the intended clinical endpoint

Ophthalmology

https://www.youtube.com/watch?v=eHQWWje4VwI&feature=youtu.be PROs have become a vital part of modern ophthalmology with an increasing focus on PROs within high-quality ophthalmic trials....

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

Biotech and eCOA vendor: A shared mindset

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA